Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-24T13:26:31.094Z Has data issue: false hasContentIssue false
  • English
  • Français

The Rational Use of Medicines

Published online by Cambridge University Press:  10 March 2009

Lars Werkö
Lars Werkö
Affiliation:
The Swedish Council on Technology Assessment in Health Care
Get access Rights & Permissions [Opens in a new window]

Abstract

A short description is given of the interplay between the pharmaceutical industry and its critics regarding the rational use of medicines since the 1960s. This was especially vigorous in the developing countries but also had ramifications in the industrialized world. The initiatives taken by the World Health Organization in starting a dialogue between the industry representatives in the International Federation of Pharmaceutical Manufacturers Associations and the critical voices of Health Action International are specially emphasized. The recent developments in the therapy of primary hypertension and peptic ulcer are discussed briefly as examples of the rapid changes in what should be rational in pharmacologic treatment of disease.

Type
Special Section: The Rational Use of Therapeutic Drugs
Information
International Journal of Technology Assessment in Health Care , Volume 11 , Issue 3 , Summer 1995 , pp. 391 - 398
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ahmad, S. R.Education and research in therapeutics in USA. Lancet, 1994, 344, 50.Google Scholar
2.Barber, M. S., & Barnacal, P. A.Bitter pills: The right kind of medicine. Richmond, Surrey, UK: PJB Publishers Ltd., 1984.Google Scholar
3.Doyal, L., & Pennell, I.The political economy of health. London: Pluto Press Ltd., 1979.Google Scholar
4.Gibbons, A.Childrens’ Vaccine Initiative stumbles. Science, 1994, 265, 1376–77.CrossRefGoogle ScholarPubMed
5.Hosking, S. W., Ling, T. K., Chung, S. C., et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet, 1994, 343, 508–10.CrossRefGoogle ScholarPubMed
6.IFPMA: Ninth Assembly, Tokyo, 1978. Zürich: IFPMA, 1979.Google Scholar
7.Joyce, C. R. B. Professionals, patients and consumers. In Gross, F. (ed), Decision making in drug research. New York: Raven Press, 1983, 109–20.Google Scholar
8.McDermott, W.Pharmaceuticals: Their role in developing societies. Science, 1980, 209, 240–45.CrossRefGoogle ScholarPubMed
9.Muller, M.The health of nations: A north-south investigation. London: Faber & Faber Ltd., 1982.Google Scholar
10.Rauws, E. A., & Tytgat, G. N.Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet, 1990, 335, 1233–35.CrossRefGoogle ScholarPubMed
11.SBU: Måttligt förhöjt blodtryck (Moderately elevated blood pressure). Report 121. Stockholm: SBU, 1994.Google Scholar
12.Tarimo, E., & Creese, A. (ed.). Achieving health for all by the year 2000: Midway repor of country experiences. Geneva: WHO, 1990, 24, 74, 176.Google Scholar
13.World Bank: World Development Report 1993, New York: Oxford University Press, 1993, 146.Google Scholar